Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 6197 of 6351
-
Could a single pill replace two? new combo drug tested in healthy volunteers
Knowledge-focused CompletedThe purpose of this study is to assess how well laroprovstat and rosuvastatin combined in a single tablet to be taken by mouth works compared with laroprovstat and rosuvastatin individual tablets taken by mouth (relative bioavailability) in healthy adults.
Phase 1 • Sponsor: AstraZeneca • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Spice up your spuds: study tests glucose monitors on potato meals
Knowledge-focused OngoingThe purpose of this study is to determine whether continuous glucose monitoring is sensitive to quantifying the glucose response related to consumption of a starchy vegetable (potato) in combination with or separate from consumption of herbs and spices at the same meal.
Sponsor: University of Alabama at Birmingham • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:05 UTC
-
Alcohol and ED meds: new study checks how sildenafil suspension performs after a drink
Knowledge-focused Not yet recruitingThis is an open-label, randomized study evaluating the pharmacokinetics and onset performance of Hezkue® oral sildenafil suspension administered following moderate alcohol consumption in healthy adult subjects. Participants will receive Hezkue® under controlled alcohol-exposure c…
Phase 1 • Sponsor: Aspargo Labs, Inc • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:06 UTC
-
New inhaled drug SYH2059 begins first human safety tests
Knowledge-focused Not yet recruitingRandomized, double-blind and placebo-controlled study to evaluate the safety, tolerability, and pharmacokinetic characteristics of SYH2059 powder for inhalation after single and multiple doses in healthy subjects. The study is composed of 2 parts. Part 1 is to assess the safety, …
Phase 1 • Sponsor: InnovStone Therapeutics Limited • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:04 UTC
-
Are your dental implants tilted differently than your real teeth?
Knowledge-focused OngoingBackground: When placing a dental implant, it is not always possible to place it exactly in the same position as the tooth that it replaced. That might be because of how the gums and mouth are shaped, since some bone is always lost after a tooth is extracted. Researchers want to…
Sponsor: Ohio State University • Aim: Knowledge-focused
Last updated Jul 30, 2026 00:00 UTC
-
Breakfast matters: study tests FWD1802 with fatty meals
Knowledge-focused OngoingA Phase I, Single-Center, Open-Label, Randomized, Single-Dose, Three-Period Crossover Study to Evaluate the Effect of High-Fat and Low-Fat Meals on the Pharmacokinetics of FWD1802 in Chinese Healthy Subjects. The primary objectives are to address the following questions: To eval…
Phase 1 • Sponsor: Forward Pharmaceuticals Co., Ltd. • Aim: Knowledge-focused
Last updated Jul 18, 2026 00:00 UTC
-
Scoliosis and cyberchondria: is dr. google making teens anxious?
Knowledge-focused Recruiting nowScoliosis is a three-dimensional torsional deformity of the spine and trunk characterized by alignment abnormalities in the coronal plane, the presence of axial rotation in the horizontal plane, and abnormalities in the normal spinal curves (lordosis-kyphosis) in the sagittal pla…
Sponsor: Izmir Democracy University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:30 UTC
-
Water at meals: could it curb your appetite?
Knowledge-focused Recruiting nowThe primary purpose of this study is to investigate the influence of including water as a beverage at a meal on food intake, and if the influence of water consumption on food consumption is moderated by switching behavior. Additionally, other individual characteristics will be ex…
Sponsor: Cornell University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:23 UTC
-
Radioactive tag reveals Drug's exit route in tiny trial
Knowledge-focused Not yet recruitingThis is an open-label, single-center, single-dose study.
Phase 1 • Sponsor: Guangdong Raynovent Biotech Co., Ltd • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:00 UTC
-
Liquid metformin study: will it work better than pills?
Knowledge-focused Not yet recruitingThe study will evaluate the pharmacokinetics and relative bioavailability of two liquid metformin formulations (100 mg/mL and 250 mg/mL)
Phase 1 • Sponsor: Aspargo Labs, Inc • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:06 UTC
-
Fish oil absorption study launches in healthy volunteers
Knowledge-focused Not yet recruitingDemographic data, medical and medication history, physical examination, 12-lead ECG, haematology, biochemistry, serology, urine routine analysis, additionally for females serum pregnancy test, hormone assay (FSH) will be done within 21 days and a chest X-ray within 06 months prio…
Sponsor: Sichuan Credit Pharmaceutical Co., Ltd. • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:01 UTC
-
New drug interaction study launches in healthy volunteers
Knowledge-focused CompletedThe purpose of the study is to assess the effect of AZD5004 on the pharmacokinetics (PK) of mitiglinide and pioglitazone in healthy participants.
Phase 1 • Sponsor: AstraZeneca • Aim: Knowledge-focused
Last updated Jul 15, 2026 00:00 UTC
-
New stroke drug candidate LWP779 begins first human safety tests
Knowledge-focused Recruiting nowThis study is a randomized, double-blind, placebo-controlled clinical trial featuring both single ascending dose (SAD), food effect and multiple ascending dose (MAD) phases intended to evaluate the safety, tolerability, PK, PD, and active metabolites of LWP779 after oral administ…
Phase 1 • Sponsor: Longwood Pharmaceuticals (Hangzhou) Co., Ltd. • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:03 UTC
-
New drug ICP-538 tested in healthy people for first time
Knowledge-focused Recruiting nowThis is a Randomized, Double-Blind, Placebo-Controlled, Single and Multiple Ascending Dose Phase I Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ICP-538 in Healthy Subjects
Phase 1 • Sponsor: Beijing InnoCare Pharma Tech Co., Ltd. • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Study probes link between body measurements and hand skills
Knowledge-focused CompletedIn this study, upper extremity anthropometric characteristics, functional upper extremity skills, and reaction time will be examined in healthy young adults. A total of 46 healthy individuals aged between 18 and 25 years, with no history of systemic disease or upper extremity inj…
Sponsor: Istinye University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:23 UTC
-
New drug BW-50218 begins first human safety tests
Knowledge-focused OngoingPhase 1, Single Ascending Dose Study of Subcutaneous BW-50218 in Healthy Participants
Phase 1 • Sponsor: Shanghai Argo Biopharmaceutical Co., Ltd. • Aim: Knowledge-focused
Last updated Sep 05, 2026 00:00 UTC
-
New drug RO7875913 tested in healthy volunteers for first time
Knowledge-focused Recruiting nowThe purpose of this study is to evaluate the safety, pharmacokinetics, and pharmacodynamics of RO7875913 in healthy participants.
Phase 1 • Sponsor: Genentech, Inc. • Aim: Knowledge-focused
Last updated Jul 22, 2026 00:00 UTC
-
Researchers test study materials for clarity before patient use
Knowledge-focused Recruiting nowPeople who are invited to take part in health research are usually given written information, such as invitation letters, and information sheets. These documents are essential because they help people understand what the study involves and decide whether they want to take part. H…
Sponsor: University of Nottingham • Aim: Knowledge-focused
Last updated Jul 02, 2026 00:00 UTC
-
Can a simple air warmer save lives in the field? tiny pilot study aims to find out.
Knowledge-focused By invitation onlyForced air warming may be a feasible strategy for prehospital rewarming of patients with accidental hypothermia. This pilot study will explore the feasibility of this technique which has not been studied outside of hospital.
Sponsor: Haukeland University Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:10 UTC
-
New drug EDG-7500 tested in healthy volunteers
Knowledge-focused CompletedThe purpose of this Phase 1 study is to understand and compare the amount of EDG-7500 in the blood after single and multiple doses in Japanese and Caucasian adults. The safety of EDG-7500 in these adult participants will also be evaluated in this study.
Phase 1 • Sponsor: Edgewise Therapeutics, Inc. • Aim: Knowledge-focused
Last updated Aug 02, 2026 00:00 UTC